ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ADVB vs AMS // EV/EBITDA & P/E VALUATION

Advanced Biomed Inc. (NASDAQ) VS. American Shared Hospital Services (NYSE) • 15-METRIC TALLY: ADVB 1 — AMS 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADVB VS. AMS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ADVB AMS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 18.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -9.10% -13.80% +4.70 ADVB /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -12.80% — TIE /operating-margins <GO>
Net Profit Margin — -5.50% — TIE /net-margins <GO>
Revenue Growth (YoY) — -0.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.46 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 AMS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 20.4 42.0 -21.67 AMS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $4.4M $8.4M -$4.0M AMS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ADVB REV AMS REV ADVB GROSS % AMS GROSS % ADVB FCF AMS FCF
FY 2025 $0 $28.1M — 18.0% -$5.9M -$4.5M
FY 2024 $0 $28.3M — 32.4% -$2.2M -$7.8M
FY 2023 — $21.3M — — — $5.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADVB // BETA —
AMS // BETA —